TROG Cancer Research 39th Annual Scientific Meeting – 9-12 March, 2027
TROG Cancer Research 39th Annual Scientific Meeting 9-12 March, 2027 Wrest Point, Hobart, Tasmania,
Featured News
TROG Cancer Research 39th Annual Scientific Meeting 9-12 March, 2027 Wrest Point, Hobart, Tasmania,
PaCCSC & CST Research Forum 2027 23-24 February 2027 International Convention Centre (ICC), Sydney
GI Cancer Trials (formerly AGITG) 28th Annual Scientific Meeting 24–27 November 2026 Hotel Grand Chancellor Hobart and online
The 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026, with pre-conference workshops being held on Tuesday 10 November.
The Melanoma and Skin Cancer Trials 2026 Scientific Meeting will bring together Australian leaders in melanoma and skin cancer clinical trials to share the latest discoveries and foster further innovative research.
A routine eye test changed Carolyn Alkemade’s life forever. Diagnosed with rare ocular melanoma, she transformed shock into purpose — now speaking publicly to raise awareness and encourage people everywhere to prioritise eye health and early detection.
Inspired by John Robson’s tale of resilience, hope and the power of clinical trials, the Australian Livestock and Property Agents Association nominated MASC Trials as its charity partner, showing what can happen when regional Australia gets behind a cause they believe in.
TrialHub celebrates five years of increasing access to trials for underserved populations including individuals diagnosed with melanoma, rare cancers and those living in outer metropolitan, regional, rural and remote areas.
We are proud to announce the successful completion of 24-months of follow-up for the IMAGE trial, a landmark study evaluating the role of Melanoma Surveillance Photography (MSP) in improving early detection of melanoma among high and ultra-high-risk patients.
Leading skin care brand Avène has raised nearly $39,000 to support clinical trials led by Melanoma and Skin Cancer Trials.